USFD Approved New Drug Leqembi containing lecanemab-irmb for early stage of Alzheimer’s Disease
New drug Leqembi containing lecanemab-irmb for treatment of Alzheimer’s disease approved by US FDA under accelerated approval pathway. There are very few treatments available for treatment of Alzheimer’s disease, people affected…